Search results
Metabolic syndrome a scary epidemic that few can define
United Press International via Yahoo News· 15 hours agoNot many people know what metabolic syndrome is, even though the cluster of conditions impacts their...
How to Ask a Doctor for Antidepressants
MediaFeed via AOL· 7 days agoWhen you’re depressed, seemingly small tasks or activities like brushing your teeth, cooking your favorite carbonara or grabbing after-work drinks can...
Metabolic syndrome a scary epidemic that few can define
UPI· 15 hours ago1 of 4 | Having unhealthy levels of sugar and fat in the blood, elevated cholesterol, high blood...
Finding Opportunity in Unloved Healthcare ETFs | ETF Trends
ETF Trends· 13 hours agoThe healthcare sector was a weak performer in 2023. Year-to-date, the healthcare sector as measured...
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
CNBC· 2 days agoTelehealth company Ro on Wednesday launched a new tracker to help patients find a popular class of weight loss and diabetes drugs called GLP-1s amid shortages ...
We fact-checked a famous plagiarist’s book on Ozempic – and uncovered a string of errors
The Telegraph via Yahoo News· 2 days agoBut, within days of the publication of his latest book, Magic Pill, which explores the risks and...
Could drugs like Ozempic and Wegovy help people live longer? Some experts see them as potential...
Fortune via Yahoo Finance· 6 days agoThey work by activating GLP-1 receptors and increasing insulin levels in the body and thereby...
Testosterone and Hair Loss: What's the Link?
MediaFeed via AOL· 6 days agoHmmmm…is that more hair than usual circling the shower drain? Or are you just being paranoid? The truth is, male androgenetic alopecia (AGA) — also known...
France against Servier selling generics unit Biogaran, PM says
Reuters via AOL· 2 days agoPARIS (Reuters) -The French government has told drugmaker Servier it is against any sale of its...
What are alternatives to Ozempic and Wegovy and are they safe?
Medical Xpress· 4 days agoRecent shortages of the brand-name drugs have opened the door to copycat versions that, while legal, also raise some concerns for consumers, says Kelly Ann Barnes, Northeastern professor of ...
